OpenAI acquires startup Orchestra Bio to beef up its biotech business
techcrunch.comJulie Bort
OpenAI acquires Orchestra Bio to strengthen its biotech capabilities, integrating the startup's team and technology into Rosalind, an AI model for life sciences research, and its associated Rosalind Workbench tool for experiment planning and analysis.
Why it mattersThis acquisition signals OpenAI's commitment to the biotech sector and expands the practical applications of its AI models beyond general-purpose tasks into specialized scientific research workflows.
From the source: OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.Read at techcrunch.com